Ingalls & Snyder LLC Has $52,000 Holdings in Cardlytics, Inc. (NASDAQ:CDLX)

Ingalls & Snyder LLC lessened its stake in Cardlytics, Inc. (NASDAQ:CDLXFree Report) by 45.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 14,050 shares of the company’s stock after selling 11,602 shares during the quarter. Ingalls & Snyder LLC’s holdings in Cardlytics were worth $52,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Check Capital Management Inc. CA boosted its holdings in Cardlytics by 10.4% during the third quarter. Check Capital Management Inc. CA now owns 50,650 shares of the company’s stock worth $162,000 after purchasing an additional 4,775 shares during the last quarter. BNP Paribas Financial Markets boosted its holdings in Cardlytics by 32.1% during the third quarter. BNP Paribas Financial Markets now owns 19,745 shares of the company’s stock worth $63,000 after purchasing an additional 4,796 shares during the last quarter. SG Americas Securities LLC boosted its holdings in Cardlytics by 38.2% during the fourth quarter. SG Americas Securities LLC now owns 19,490 shares of the company’s stock worth $72,000 after purchasing an additional 5,392 shares during the last quarter. Creative Planning boosted its holdings in Cardlytics by 35.4% during the third quarter. Creative Planning now owns 29,537 shares of the company’s stock worth $95,000 after purchasing an additional 7,721 shares during the last quarter. Finally, Tallon Kerry Patrick acquired a new position in Cardlytics during the fourth quarter worth $37,000. Institutional investors and hedge funds own 68.10% of the company’s stock.

Cardlytics Trading Up 2.3 %

CDLX opened at $3.56 on Friday. The company’s 50 day moving average is $3.49 and its 200-day moving average is $3.85. Cardlytics, Inc. has a 1-year low of $2.76 and a 1-year high of $20.52. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40. The company has a market cap of $180.93 million, a P/E ratio of -0.58 and a beta of 1.54.

Insider Activity at Cardlytics

In related news, CFO Alexis Desieno sold 8,854 shares of the firm’s stock in a transaction that occurred on Friday, January 3rd. The shares were sold at an average price of $3.67, for a total value of $32,494.18. Following the completion of the transaction, the chief financial officer now owns 121,976 shares in the company, valued at $447,651.92. This trade represents a 6.77 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Amit Gupta sold 15,160 shares of the firm’s stock in a transaction that occurred on Friday, January 24th. The stock was sold at an average price of $3.92, for a total transaction of $59,427.20. Following the transaction, the chief executive officer now owns 215,494 shares of the company’s stock, valued at approximately $844,736.48. The trade was a 6.57 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 39,819 shares of company stock worth $148,305 in the last quarter. 4.40% of the stock is owned by insiders.

Analyst Ratings Changes

Several research analysts recently commented on the stock. Needham & Company LLC restated a “hold” rating on shares of Cardlytics in a report on Friday, January 17th. Craig Hallum upgraded shares of Cardlytics from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, November 6th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $6.92.

View Our Latest Stock Analysis on CDLX

Cardlytics Profile

(Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Recommended Stories

Institutional Ownership by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.